For investors, the temptation to outsmart the market is constant. Complex trading strategies, hot stock tips and sophisticated portfolio tactics promise superior returns. But decades of evidence tell ...

Cullinan Therapeutics has a robust T-cell engager pipeline, savvy management, and a strong cash position. Read more on what investors should know about the company.

Zero-day exploits, AI-driven Android malware, firmware backdoors, password manager trust gaps, rising DDoS define this week’s critical cyber threats.